These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mesalamine derivatives in the treatment of Crohn's disease. Harrell LE; Hanauer SB Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540 [TBL] [Abstract][Full Text] [Related]
3. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204 [TBL] [Abstract][Full Text] [Related]
4. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature]. Neĭman KP; Rumiantsev VG Eksp Klin Gastroenterol; 2006; (3):56-60. PubMed ID: 17203844 [No Abstract] [Full Text] [Related]
5. Pediatric Crohn's disease in South India. Sathiyasekaran M; Raju BB; Shivbalan S; Rajarajan K Indian Pediatr; 2005 May; 42(5):459-63. PubMed ID: 15923692 [TBL] [Abstract][Full Text] [Related]
6. Nutritional supplementation with polymeric diet enriched with transforming growth factor-beta 2 for children with Crohn's disease. Hartman C; Berkowitz D; Weiss B; Shaoul R; Levine A; Adiv OE; Shapira R; Fradkin A; Wilschanski M; Tamir A; Shamir R Isr Med Assoc J; 2008 Jul; 10(7):503-7. PubMed ID: 18751627 [TBL] [Abstract][Full Text] [Related]
7. Sex-specific risks for pediatric onset among patients with Crohn's disease. Montgomery SM; Wakefield AJ; Ekbom A Clin Gastroenterol Hepatol; 2003 Jul; 1(4):303-9. PubMed ID: 15017672 [TBL] [Abstract][Full Text] [Related]
8. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease. Picco MF; Zubiaurre I; Adluni M; Cangemi JR; Shelton D Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832 [TBL] [Abstract][Full Text] [Related]
9. Metastatic crohn's disease--penile and scrotal involvement. Martínez-Salamanca JI; Jara J; Miralles P; Berenguer J; Del Valle E; Hernández C Scand J Urol Nephrol; 2004; 38(5):436-7. PubMed ID: 15764258 [TBL] [Abstract][Full Text] [Related]
11. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease. Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504 [TBL] [Abstract][Full Text] [Related]
12. Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature. Basturk T; Ozagari A; Ozturk T; Kusaslan R; Unsal A J Ren Care; 2009 Sep; 35(3):147-50. PubMed ID: 19689697 [TBL] [Abstract][Full Text] [Related]
13. A two-year longitudinal study of persistent lean tissue deficits in children with Crohn's disease. Sylvester FA; Leopold S; Lincoln M; Hyams JS; Griffiths AM; Lerer T Clin Gastroenterol Hepatol; 2009 Apr; 7(4):452-5. PubMed ID: 19249399 [TBL] [Abstract][Full Text] [Related]
14. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505 [TBL] [Abstract][Full Text] [Related]
15. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Afzal NA; Van Der Zaag-Loonen HJ; Arnaud-Battandier F; Davies S; Murch S; Derkx B; Heuschkel R; Fell JM Aliment Pharmacol Ther; 2004 Jul; 20(2):167-72. PubMed ID: 15233696 [TBL] [Abstract][Full Text] [Related]
17. Review article: chronic active disease and maintaining remission in Crohn's disease. Kamm MA Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904 [TBL] [Abstract][Full Text] [Related]
18. [Oral manifestations in Crohn's disease and dental management]. Orosz M; Sonkodi I Fogorv Sz; 2004 Jun; 97(3):113-7. PubMed ID: 15282976 [TBL] [Abstract][Full Text] [Related]
19. Crohn's disease of the vulva in a 10-year-old girl. Kuloğlu Z; Kansu A; Demirçeken F; Bozkir M; Kundakçi N; Bingöl-Koloğlu M; Girgin N Turk J Pediatr; 2008; 50(2):197-9. PubMed ID: 18664090 [TBL] [Abstract][Full Text] [Related]
20. MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): technical aspects and findings in patients affected by Crohn's disease. Laghi A; Paolantonio P; Iafrate F; Borrelli O; Dito L; Tomei E; Cucchiara S; Passariello R Radiol Med; 2003; 106(1-2):18-27. PubMed ID: 12951547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]